健康元：健康元药业集团股份有限公司2022年第一季度报告（英文版）.PDF

1、Joincare Pharmaceutical Group Industry Co.,Ltd.2022 First Quarterly Report 1/16 Stock code：600380 Stock abbreviation：健康元 Joincare Pharmaceutical Group Industry Co.,Ltd 2022 First Quarterly Report Board of Directors(the“Board”)and all Directors of the Company hereby warrant that there are no false re

2、presentations,misleading statements or material omissions contained in this report,and severally and jointly accept responsibility for the truthfulness,accuracy and completeness of the contents of the Report.IMPORTANT NOTICE(I)The Board,the Supervisory Committee and the Directors,Supervisors and sen

3、ior management of the Company hereby warrant the truthfulness,accuracy and completeness of the contents of quarterly reports,and that there are no false representations,misleading statements or material omissions contained in the Report,and severally and jointly accept responsibility.(II)The person-

4、in-charge of the Company,the person-in-charge of the Companys accounting work and the person-in-charge of the accounting department(the head of the accounting department)hereby warrant the truthfulness,accuracy and completeness of the financial statements contained in quarterly reports.(III)Whether

5、the first quarterly financial statements are audited Applicable N/A(IV)The Report is prepared in both Chinese and English.In case of any ambiguity in the understanding of the Chinese and English texts,the Chinese version shall prevail.I Principal Financial Data(I)Principal accounting data and financ

6、ial indicators Unit:Yuan Currency:RMB Item The Reporting Period:(January-March 2022)Year-on-Year Change(%)Revenues 4,657,343,538.89 12.36 Net profit attributable to Shareholders of the listed company 460,537,813.53 25.52 Net profit attributable to Shareholders of the listed company after deducting t